Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension

Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension

Abstract Optimal management of systemic lupus erythematosus (SLE)‐associated pulmonary arterial hypertension (PAH) remains unclear. Our observation describes the case of a 31‐year‐old SLE patient presenting with cardiogenic shock revealing severe PAH, in which a therapeutic scheme combining immunosu...

Full description

Bibliographic Details
Main Authors: Sébastien Sanges, Laurent Savale, Nicolas Lamblin, Martine Rémy‐Jardin, Marc Humbert, Vincent Sobanski
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:ESC Heart Failure
Subjects:
Pulmonary arterial hypertension
Systemic lupus erythematosus
Immunosuppressants
Online Access:https://doi.org/10.1002/ehf2.12507

Internet

https://doi.org/10.1002/ehf2.12507

Similar Items